Chart

Aligos Therapeutics, Inc.

ALGS

Jan 1 1970 00:00:00

10.55

▲0.1750▲1.69%

Open10.79

High10.79

Low10.28

Close10.37

Volume1.16k

EPS

-10.24

P/E

-1.03

Market Cap

449.31M

Outstanding Shares

42.61M

Soon

Sentiment

Soon

Options

Recent Filings

ID: 0001610717-24-000503

ID: 0001610717-24-000495

ID: 0001783647-24-000001

ID: 0001610717-24-000466

ID: 0001610717-24-000465

ID: 0001610717-24-000464

ID: 0001193125-24-214188

ID: 0001193125-24-202813

ID: 0001610717-24-000423

ID: 0001610717-24-000422

You might find these companies interesting

Cero Therapeutics Holdings, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Inmune Bio, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Gamida Cell Ltd.

Biological Products, (No Diagnostic Substances) (2836)

Sorrento Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Cero Therapeutics Holdings, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Biological Products, (No Diagnostic Substances) (2836)

Passage Bio, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Biological Products, (No Diagnostic Substances) (2836)

Chromocell Therapeutics Corp

Biological Products, (No Diagnostic Substances) (2836)

Atara Biotherapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Genetic Technologies Ltd

Biological Products, (No Diagnostic Substances) (2836)

Aptose Biosciences Inc.

Biological Products, (No Diagnostic Substances) (2836)

Kronos Bio, Inc.

Pharmaceutical Preparations (2834)

Sage Therapeutics, Inc.

Pharmaceutical Preparations (2834)